Inflammatory Disease Markers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Inflammatory Disease Markers Pipeline Market Report Overview

Inflammatory disease markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity.

The inflammatory disease markers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests

·       C-Reactive Protein (CRP) Analyzer Tests

·       C-Reactive Protein (CRP) Automated Tests

·       Anti-Cyclic Citrullinated Peptide Antibody (anti-CCP) Automated Tests

·       Analyzer Based Tests

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       South Korea

Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA

·       TGA

·       UKCA

Leading Companies ·       1Drop Diagnostics

·       4F Biotech Srl

·       Abcodia Ltd

·       Adaltis Srl

·       Age Labs AS

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Inflammatory Disease Markers Pipeline Market by Segments

The key segments of the inflammatory disease markers pipeline market are anti-cyclic citrullinated peptide antibody (Anti-CCP) analyzer tests, C-reactive protein (CRP) analyzer tests, C-reactive protein (CRP) automated tests, anti-cyclic citrullinated peptide antibody (anti-CCP) automated tests, and analyzer based tests. As of August 2024, the anti-cyclic citrullinated peptide antibody (Anti-CCP) analyzer tests segment accounted for the highest share of pipeline products.

Inflammatory Disease Markers Pipeline Market Analysis by Segments, 2024 (%)

Inflammatory Disease Markers Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Inflammatory Disease Markers Pipeline Market

Download a Free Report Sample

Inflammatory Disease Markers Pipeline Market Segmentation by Territories

A few of the key territories with the inflammatory disease markers pipeline market are the US, Europe, China, Australia, and South Korea. As of August 2024, the US accounted for the highest number of pipeline products.

Inflammatory Disease Markers Pipeline Market Analysis by Territories, 2024 (%)

Inflammatory Disease Markers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Inflammatory Disease Markers Pipeline Market

Download a Free Report Sample

Inflammatory Disease Markers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the inflammatory disease markers pipeline products market are 510(k), CE-IVD, NMPA, TGA, and UKCA. As of August 2024, 510(k) was the most followed pathway for pipeline products in the inflammatory disease markers market.

Inflammatory Disease Markers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Inflammatory Disease Markers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Inflammatory Disease Markers Pipeline Market

Download a Free Report Sample

Inflammatory Disease Markers Pipeline Market – Competitive Landscape

A few of the key companies associated with the inflammatory disease markers pipeline market are 1Drop Diagnostics, 4F Biotech Srl, Abcodia Ltd, Adaltis Srl, and Age Labs AS, among others.

Abcodia Ltd: Abcodia is headquartered in Cambridge, the UK. It is a clinical-stage company offering commercial development of novel, scientifically validated tests for the early detection of cancer. The company validates and discovers biomarkers for early diagnosis and screening of cancer. Abcodia develops products for the detection of colorectal cancer, pancreatic cancer, and lung cancer.

Adaltis Srl: Adaltis is headquartered in Rome, Italy. It is an international IVD company that develops, manufactures, and markets in-vitro diagnostic systems and reagents. Its products include IVD instruments, IVD reagents, molecular diagnostic instruments, and molecular diagnostic tests, among others. Adaltis also develops systems and reagents for molecular diagnostic and PCR testing (extraction and purification platform). Its service offerings include conjugate production activities and OEM services.

Inflammatory Disease Markers Pipeline Market Analysis by Companies, 2024

Inflammatory Disease Markers Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Inflammatory Disease Markers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Inflammatory Disease Markers Pipeline Market Segments Outlook (2024)

  • Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests
  • C-Reactive Protein (CRP) Analyzer Tests
  • C-Reactive Protein (CRP) Automated Tests
  • Anti-Cyclic Citrullinated Peptide Antibody (anti-CCP) Automated Tests
  • Analyzer Based Tests

Inflammatory Disease Markers Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Australia
  • South Korea

Inflammatory Disease Markers Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • NMPA
  • TGA
  • UKCA

Scope

This report provides:

  • Extensive coverage of the inflammatory disease markers under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of inflammatory disease markers and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of inflammatory disease markers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

1Drop Diagnostics
4F Biotech Srl
Abcodia Ltd
Adaltis Srl
Age Labs AS
Albert Ludwigs University of Freiburg
AnaMar AB
Anteotech Ltd
Aqtual Inc
Arizona State University
AXO Science SAS
Beckman Coulter Inc
BIOHOPE Scientific SL
Biomedal SL
BioMEMS Diagnostics Inc
BiomX Inc
BioSIMS
Boditech Med Inc
BRI Pharma Co Ltd
Castle Biosciences Inc
CD Diagnostics Inc
CDI Laboratories Inc
Cernostics Inc
Chronix Biomedical Inc
Cincinnati Children's Hospital Medical Center
Crescendo Bioscience Inc
Cyted Ltd
Detact Diagnostics BV
Diafir
DiaSorin SpA
DSX Therapeutics LLC
EKF Diagnostics Holdings Plc
ELITechGroup Inc
EMD Millipore Corp
ET Healthcare Inc
Exagen Diagnostics Inc
Firalis SAS
French National Institute of Health and Medical Research
G Medical Health and Wellness
Genalyte Inc
Geneoscopy LLC
Genetic Analysis AS
Genfit SA
Ghent University
GoodGut SL
Guangzhou Wondfo Biotech Co Ltd
Helmholtz Center Munich German Research Center for Health and Environment GmbH
Ignyta Inc
InterVenn BioSciences
IPDx Immunoprofiling Diagnostics GmbH
IV Diagnostics Inc
Johns Hopkins University
KineMed Inc
Korea Basic Science Institute
Ladon Therapeutics Kft
Leiden University
LifeAssays AB
LightDeck Diagnostics Inc
Mabdx Inc
Medica Corp
Metabolon Inc
Morehouse School of Medicine
MyHealthChecked plc
MYND Diagnostics Ltd
Myriad Genetics Inc
Nagoya City University
Neoteryx LLC
Northwestern University
Ortho Clinical Diagnostics Holdings Plc
Oxford Biodynamics Plc
Paragraf Ltd
Phagolum Ltd.
Proplex Technologies Llc
Protagen AG
ProteinLogic Ltd
QSTAG Co Ltd
Queen Mary University of London
Roche Diagnostics Corp
ROMEG Therapeutics LLC
Scailyte AG
Siemens Healthcare Diagnostics Inc
Singulex Inc
SomaLogic Inc
SpinChip Diagnostics AS
SQI Diagnostics Inc
StageZero Life Sciences Ltd
Svar Life Science AB
The University of Manchester
The Walter and Eliza Hall Institute of Medical Research
Thermo Fisher Scientific Inc
Toscana Biomarkers Srl
University Health Network
University Hospital Hradec Kralove
University of Aberdeen
University of Auckland
University of California
University of California Los Angeles
University of California San Diego
University of California San Francisco
University of Gottingen
University of Newcastle
University of Oxford
University of Rochester
University of Warwick
University Rovira i Virgili

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 16

2 Introduction 17

2.1 Inflammatory Disease Markers Overview 17

3 Products under Development 18

3.1 Inflammatory Disease Markers – Pipeline Products by Stage of Development 18

3.2 Inflammatory Disease Markers – Pipeline Products by Segment 19

3.3 Inflammatory Disease Markers – Pipeline Products by Territory 20

3.4 Inflammatory Disease Markers – Pipeline Products by Regulatory Path 21

3.5 Inflammatory Disease Markers – Pipeline Products by Estimated Approval Date 22

3.6 Inflammatory Disease Markers – Ongoing Clinical Trials 23

4 Inflammatory Disease Markers – Pipeline Products under Development by Companies 24

4.1 Inflammatory Disease Markers Companies – Pipeline Products by Stage of Development 24

4.2 Inflammatory Disease Markers – Pipeline Products by Stage of Development 28

5 Inflammatory Disease Markers Companies and Product Overview 32

5.1 Company Overview 32

5.2 1Drop Diagnostics Company Overview 32

5.2.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 32

5.3 4F Biotech Srl Company Overview 33

5.3.1 4F Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview 33

5.4 Abcodia Ltd Company Overview 34

5.4.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.5 Adaltis Srl Company Overview 35

5.5.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Age Labs AS Company Overview 36

5.6.1 Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview 36

5.7 Albert Ludwigs University of Freiburg Company Overview 37

5.7.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37

5.8 AnaMar AB Company Overview 38

5.8.1 AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 Anteotech Ltd Company Overview 39

5.9.1 Anteotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.10 Aqtual Inc Company Overview 40

5.10.1 Aqtual Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.11 Arizona State University Company Overview 43

5.11.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 43

5.12 AXO Science SAS Company Overview 44

5.12.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 44

5.13 Beckman Coulter Inc Company Overview 45

5.13.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.14 BIOHOPE Scientific SL Company Overview 54

5.14.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 Biomedal SL Company Overview 55

5.15.1 Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview 55

5.16 BioMEMS Diagnostics Inc Company Overview 56

5.16.1 BioMEMS Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.17 BiomX Inc Company Overview 57

5.17.1 BiomX Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.18 BioSIMS Company Overview 58

5.18.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 58

5.19 Boditech Med Inc Company Overview 59

5.19.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.20 BRI Pharma Co Ltd Company Overview 60

5.20.1 BRI Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.21 Castle Biosciences Inc Company Overview 61

5.21.1 Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.22 CD Diagnostics Inc Company Overview 62

5.22.1 CD Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.23 CDI Laboratories Inc Company Overview 63

5.23.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.24 Cernostics Inc Company Overview 64

5.24.1 Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.25 Chronix Biomedical Inc Company Overview 66

5.25.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.26 Cincinnati Children’s Hospital Medical Center Company Overview 67

5.26.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 67

5.27 Crescendo Bioscience Inc Company Overview 68

5.27.1 Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.28 Cyted Ltd Company Overview 69

5.28.1 Cyted Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.29 Detact Diagnostics BV Company Overview 70

5.29.1 Detact Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 70

5.30 Diafir Company Overview 71

5.30.1 Diafir Pipeline Products & Ongoing Clinical Trials Overview 71

5.31 DiaSorin SpA Company Overview 72

5.31.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 72

5.32 DSX Therapeutics LLC Company Overview 73

5.32.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.33 EKF Diagnostics Holdings Plc Company Overview 74

5.33.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 74

5.34 ELITechGroup Inc Company Overview 75

5.34.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.35 EMD Millipore Corp Company Overview 77

5.35.1 EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 77

5.36 ET Healthcare Inc Company Overview 78

5.36.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.37 Exagen Diagnostics Inc Company Overview 79

5.37.1 Exagen Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.38 Firalis SAS Company Overview 81

5.38.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 81

5.39 French National Institute of Health and Medical Research Company Overview 82

5.39.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 82

5.40 G Medical Health and Wellness Company Overview 83

5.40.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 83

5.41 Genalyte Inc Company Overview 84

5.41.1 Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.42 Geneoscopy LLC Company Overview 85

5.42.1 Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.43 Genetic Analysis AS Company Overview 86

5.43.1 Genetic Analysis AS Pipeline Products & Ongoing Clinical Trials Overview 86

5.44 Genfit SA Company Overview 87

5.44.1 Genfit SA Pipeline Products & Ongoing Clinical Trials Overview 87

5.45 Ghent University Company Overview 88

5.45.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 88

5.46 GoodGut SL Company Overview 89

5.46.1 GoodGut SL Pipeline Products & Ongoing Clinical Trials Overview 89

5.47 Guangzhou Wondfo Biotech Co Ltd Company Overview 90

5.47.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.48 Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview 93

5.48.1 Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

5.49 Ignyta Inc Company Overview 95

5.49.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.50 InterVenn BioSciences Company Overview 96

5.50.1 InterVenn BioSciences Pipeline Products & Ongoing Clinical Trials Overview 96

5.51 IPDx Immunoprofiling Diagnostics GmbH Company Overview 97

5.51.1 IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 97

5.52 IV Diagnostics Inc Company Overview 98

5.52.1 IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 98

5.53 Johns Hopkins University Company Overview 99

5.53.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 99

5.54 KineMed Inc Company Overview 101

5.54.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.55 Korea Basic Science Institute Company Overview 102

5.55.1 Korea Basic Science Institute Pipeline Products & Ongoing Clinical Trials Overview 102

5.56 Ladon Therapeutics Kft Company Overview 103

5.56.1 Ladon Therapeutics Kft Pipeline Products & Ongoing Clinical Trials Overview 103

5.57 Leiden University Company Overview 104

5.57.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 104

5.58 LifeAssays AB Company Overview 105

5.58.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 105

5.59 LightDeck Diagnostics Inc Company Overview 106

5.59.1 LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.60 Mabdx Inc Company Overview 107

5.60.1 Mabdx Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.61 Medica Corp Company Overview 108

5.61.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 108

5.62 Metabolon Inc Company Overview 109

5.62.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.63 Morehouse School of Medicine Company Overview 110

5.63.1 Morehouse School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 110

5.64 MyHealthChecked plc Company Overview 111

5.64.1 MyHealthChecked plc Pipeline Products & Ongoing Clinical Trials Overview 111

5.65 MYND Diagnostics Ltd Company Overview 112

5.65.1 MYND Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

5.66 Myriad Genetics Inc Company Overview 113

5.66.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.67 Nagoya City University Company Overview 114

5.67.1 Nagoya City University Pipeline Products & Ongoing Clinical Trials Overview 114

5.68 Neoteryx LLC Company Overview 115

5.68.1 Neoteryx LLC Pipeline Products & Ongoing Clinical Trials Overview 115

5.69 Northwestern University Company Overview 116

5.69.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 116

5.70 Ortho Clinical Diagnostics Holdings Plc Company Overview 117

5.70.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 117

5.71 Oxford Biodynamics Plc Company Overview 121

5.71.1 Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 121

5.72 Paragraf Ltd Company Overview 122

5.72.1 Paragraf Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.73 Phagolum Ltd. Company Overview 123

5.73.1 Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 123

5.74 Proplex Technologies Llc Company Overview 124

5.74.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 124

5.75 Protagen AG Company Overview 125

5.75.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 125

5.76 ProteinLogic Ltd Company Overview 126

5.76.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.77 QSTAG Co Ltd Company Overview 127

5.77.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.78 Queen Mary University of London Company Overview 128

5.78.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 128

5.79 Roche Diagnostics Corp Company Overview 130

5.79.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 130

5.80 ROMEG Therapeutics LLC Company Overview 132

5.80.1 ROMEG Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 132

5.81 Scailyte AG Company Overview 133

5.81.1 Scailyte AG Pipeline Products & Ongoing Clinical Trials Overview 133

5.82 Siemens Healthcare Diagnostics Inc Company Overview 134

5.82.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.83 Singulex Inc Company Overview 144

5.83.1 Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.84 SomaLogic Inc Company Overview 148

5.84.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 148

5.85 SpinChip Diagnostics AS Company Overview 149

5.85.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 149

5.86 SQI Diagnostics Inc Company Overview 150

5.86.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 150

5.87 StageZero Life Sciences Ltd Company Overview 151

5.87.1 StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

5.88 Svar Life Science AB Company Overview 152

5.88.1 Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview 152

5.89 The University of Manchester Company Overview 154

5.89.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 154

5.90 The Walter and Eliza Hall Institute of Medical Research Company Overview 157

5.90.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 157

5.91 Thermo Fisher Scientific Inc Company Overview 158

5.91.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 158

5.92 Toscana Biomarkers Srl Company Overview 159

5.92.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 159

5.93 University Health Network Company Overview 160

5.93.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 160

5.94 University Hospital Hradec Kralove Company Overview 161

5.94.1 University Hospital Hradec Kralove Pipeline Products & Ongoing Clinical Trials Overview 161

5.95 University of Aberdeen Company Overview 162

5.95.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 162

5.96 University of Auckland Company Overview 163

5.96.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 163

5.97 University of California Company Overview 164

5.97.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 164

5.98 University of California Los Angeles Company Overview 165

5.98.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 165

5.99 University of California San Diego Company Overview 166

5.99.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 166

5.100 University of California San Francisco Company Overview 167

5.100.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 167

5.101 University of Gottingen Company Overview 168

5.101.1 University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 168

5.102 University of Newcastle Company Overview 169

5.102.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 169

5.103 University of Oxford Company Overview 170

5.103.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 170

5.104 University of Rochester Company Overview 171

5.104.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 171

5.105 University of Warwick Company Overview 172

5.105.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 172

5.106 University Rovira i Virgili Company Overview 173

5.106.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 173

6 Inflammatory Disease Markers- Recent Developments 174

6.1 Aug 01, 2024: Geneoscopy’s Novel Stool-Based RNA Platform Shows High Accuracy in Monitoring Crohn’s Disease 174

6.2 Jul 30, 2024: Scipher Medicine Launches a New Approach to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases 174

6.3 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024 175

6.4 Jun 24, 2024: Recent Aga Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ Tissuecypher Test 175

6.5 Jun 17, 2024: GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+ as Key Tool for Detecting At-Risk MASH 176

6.6 Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting 176

6.7 May 16, 2024: Oxford Biodynamics and King’s College London Collaborate to Develop EpiSwitch Prognostic and Predictive Biomarkers for Best Prevention of Rheumatoid Arthritis Following the APIPPRA Trial 177

6.8 May 16, 2024: Taking Cytokine Testing by Storm: Automated 7-Test Inflammation Panel from Siemens Healthineers Offers Faster Insights, More Information 178

6.9 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter 178

6.10 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics 180

6.11 Feb 21, 2024: Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 181

6.12 Jan 29, 2024: Siemens Healthcare Diagnostics Receives FDA 510(k) Clearance for Atellica CH High Sensitivity C-Reactive Protein 2 Assay 181

6.13 Jan 03, 2024: Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference 181

6.14 Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference 181

6.15 Dec 20, 2023: Siemens Healthcare Diagnostics Receives 510(k) Clearance For CardioPhase hsCRP Assay 182

6.16 Dec 06, 2023: GENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical Trials 182

6.17 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes 183

6.18 Nov 16, 2023: Non-Invasive Paper Chip Developed To Diagnose Inflammation and Infection 183

6.19 Sep 26, 2023: GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology 184

6.20 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference 184

6.21 Aug 17, 2023: Myriad Genetics to Host Investor Day on September 19, 2023 185

6.22 Aug 16, 2023: LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24 185

7 Appendix 186

7.1 Methodology 186

7.2 About GlobalData 189

7.3 Contact Us 189

7.4 Disclaimer 189

Table

Inflammatory Disease Markers – Pipeline Products by Stage of Development 18

Inflammatory Disease Markers – Pipeline Products by Segment 19

Inflammatory Disease Markers – Pipeline Products by Territory 20

Inflammatory Disease Markers – Pipeline Products by Regulatory Path 21

Inflammatory Disease Markers – Pipeline Products by Estimated Approval Date 22

Inflammatory Disease Markers – Ongoing Clinical Trials 23

Inflammatory Disease Markers Companies – Pipeline Products by Stage of Development 24

Inflammatory Disease Markers – Pipeline Products by Stage of Development 28

1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 32

High-sensitivity C-reactive protein (hs-CRP) Test – Product Status 32

High-sensitivity C-reactive protein (hs-CRP) Test – Product Description 32

4F Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview 33

Screening Test – Rheumatoid Arthritis – Product Status 33

Screening Test – Rheumatoid Arthritis – Product Description 33

Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Molecular Biomarker – Rheumatoid Arthritis – Product Status 34

Molecular Biomarker – Rheumatoid Arthritis – Product Description 34

Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 35

Hemo One – hs – CRP Assay – Product Status 35

Hemo One – hs – CRP Assay – Product Description 35

Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview 36

Rheumatoid Arthritis Test – Product Status 36

Rheumatoid Arthritis Test – Product Description 36

Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37

Diagnostic Kit – Rheumatoid Arthritis – Product Status 37

Diagnostic Kit – Rheumatoid Arthritis – Product Description 37

AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 38

NeoSix Biomarker Assay – Product Status 38

NeoSix Biomarker Assay – Product Description 38

Anteotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Sepsis PCT Assay – Product Status 39

Sepsis PCT Assay – Product Description 39

Aqtual Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Molecular Diagnostic Test – Rheumatoid Arthritis – Product Status 40

Molecular Diagnostic Test – Rheumatoid Arthritis – Product Description 40

Aqtual Inc – Ongoing Clinical Trials Overview 41

Molecular Diagnostic Test – Rheumatoid Arthritis – Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to bDMARD or tsDMARD +/- csDMARD Changing Treatment to a bDMARD or tsDMARD Treatment +/- csDMARD 42

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 43

Diagnostic Test – Rheumatoid Arthritis – Product Status 43

Diagnostic Test – Rheumatoid Arthritis – Product Description 43

AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 44

Multiplexed Detection – CRP – Product Status 44

Multiplexed Detection – CRP – Product Description 44

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 45

AU480 Clinical System – anti-CCP Assay – Product Status 45

AU480 Clinical System – anti-CCP Assay – Product Description 46

AU5810 Clinical System – anti-CCP Assay – Product Status 46

AU5810 Clinical System – anti-CCP Assay – Product Description 46

AU5820 Clinical System – anti-CCP Assay – Product Status 46

AU5820 Clinical System – anti-CCP Assay – Product Description 47

AU5830 Clinical System – anti-CCP Assay – Product Status 47

AU5830 Clinical System – anti-CCP Assay – Product Description 47

AU5840 Clinical System – anti-CCP Assay – Product Status 47

AU5840 Clinical System – anti-CCP Assay – Product Description 48

AU680 Clinical System – anti-CCP Assay – Product Status 48

AU680 Clinical System – anti-CCP Assay – Product Description 48

Multisystem Inflammatory Syndrome Diagnostic Test – Product Status 49

Multisystem Inflammatory Syndrome Diagnostic Test – Product Description 49

UniCel DxC 600 – anti-CCP Assay – Product Status 49

UniCel DxC 600 – anti-CCP Assay – Product Description 50

UniCel DxC 600i Synchron Access – anti-CCP Assay – Product Status 50

UniCel DxC 600i Synchron Access – anti-CCP Assay – Product Description 50

UniCel DxC 680i Synchron Access Clinical System – anti-CCP Assay – Product Status 51

UniCel DxC 680i Synchron Access Clinical System – anti-CCP Assay – Product Description 51

UniCel DxC 800 – anti-CCP Assay – Product Status 51

UniCel DxC 800 – anti-CCP Assay – Product Description 52

UniCel DxC 860i Synchron Access Clinical System – anti-CCP Assay – Product Status 52

UniCel DxC 860i Synchron Access Clinical System – anti-CCP Assay – Product Description 52

UniCel DxC 880i Synchron Access Clinical System – anti-CCP Assay – Product Status 53

UniCel DxC 880i Synchron Access Clinical System – anti-CCP Assay – Product Description 53

BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 54

Immunobiogram – Rheumatoid Arthritis – Product Status 54

Immunobiogram – Rheumatoid Arthritis – Product Description 54

Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview 55

IVYLISA BLG – Product Status 55

IVYLISA BLG – Product Description 55

BioMEMS Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 56

BioMEMS Analyzer – Inflammatory Test Panel – Product Status 56

BioMEMS Analyzer – Inflammatory Test Panel – Product Description 56

BiomX Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Diagnostic Test – IBD – Product Status 57

Diagnostic Test – IBD – Product Description 57

BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 58

DigiPLEX Analyzer – Rheumatology Assay – Product Status 58

DigiPLEX Analyzer – Rheumatology Assay – Product Description 58

Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 59

AFIAS 6 – Anti-CCP Plus Assay – Product Status 59

AFIAS 6 – Anti-CCP Plus Assay – Product Description 59

BRI Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

B-refine – Product Status 60

B-refine – Product Description 60

Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Inflammatory Skin Disease Test – Product Status 61

Inflammatory Skin Disease Test – Product Description 61

CD Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Cygnasure Diagnostic Immunoassay – Rheumatoid Arthritis – Product Status 62

Cygnasure Diagnostic Immunoassay – Rheumatoid Arthritis – Product Description 62

CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Diagnostic Test – Rheumatoid Arthritis – Product Status 63

Diagnostic Test – Rheumatoid Arthritis – Product Description 63

Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

TissueCypher Esophagitis Test – Product Status 64

TissueCypher Esophagitis Test – Product Description 64

TissueCypher Inflammatory Bowel Disease Test – Product Status 65

TissueCypher Inflammatory Bowel Disease Test – Product Description 65

Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Companion Diagnostic Test – Rheumatoid Arthritis – Product Status 66

Companion Diagnostic Test – Rheumatoid Arthritis – Product Description 66

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 67

Diagnostic And Prognostic Assay – Crohn’s Disease – Product Status 67

Diagnostic And Prognostic Assay – Crohn’s Disease – Product Description 67

Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Multi-Biomarker Test – Inflammatory Diseases – Product Status 68

Multi-Biomarker Test – Inflammatory Diseases – Product Description 68

Cyted Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

Diagnostic Assay – Inflammatory Diseases – Product Status 69

Diagnostic Assay – Inflammatory Diseases – Product Description 69

Detact Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 70

SynoTact – Product Status 70

SynoTact – Product Description 70

Diafir Pipeline Products & Ongoing Clinical Trials Overview 71

Rheumatoid Arthritis Diagnostic Assay – Product Status 71

Rheumatoid Arthritis Diagnostic Assay – Product Description 71

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 72

Calprotectin 3.0 – Product Status 72

Calprotectin 3.0 – Product Description 72

DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 73

Diagnostic Test – Rheumatoid Arthritis – Product Status 73

Diagnostic Test – Rheumatoid Arthritis – Product Description 73

EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 74

Quo-Lab – C-Reactive Protein – Product Status 74

Quo-Lab – C-Reactive Protein – Product Description 74

ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Eon CRP Wide Range Assay – Product Status 75

Eon CRP Wide Range Assay – Product Description 75

Selectra ProS Chemistry System – CRP Wide Range Assay – Product Status 76

Selectra ProS Chemistry System – CRP Wide Range Assay – Product Description 76

EMD Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 77

Erenna System – Rheumatoid Arthritis – Product Status 77

Erenna System – Rheumatoid Arthritis – Product Description 77

ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Pylon Assay – Full range CRP – Product Status 78

Pylon Assay – Full range CRP – Product Description 78

Exagen Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

AVISE RADR – Product Status 79

AVISE RADR – Product Description 79

AVISE SLE Monitor 2.0 – Product Status 80

AVISE SLE Monitor 2.0 – Product Description 80

Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 81

Biomarker Test – Rheumatoid Arthritis – Product Status 81

Biomarker Test – Rheumatoid Arthritis – Product Description 81

French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 82

GPI Biomarker Assay – Arthritis – Product Status 82

GPI Biomarker Assay – Arthritis – Product Description 82

G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 83

Inflammation Test – Product Status 83

Inflammation Test – Product Description 83

Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Maverick Rheumatoid Arthritis Multiplex Assay Kit – Product Status 84

Maverick Rheumatoid Arthritis Multiplex Assay Kit – Product Description 84

Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview 85

Diagnostic Test – IBD – Product Status 85

Diagnostic Test – IBD – Product Description 85

Genetic Analysis AS Pipeline Products & Ongoing Clinical Trials Overview 86

Diagnostic Test – Inflammatory Bowel Disease – Product Status 86

Diagnostic Test – Inflammatory Bowel Disease – Product Description 86

Genfit SA Pipeline Products & Ongoing Clinical Trials Overview 87

NIS2+ – Product Status 87

NIS2+ – Product Description 87

Ghent University Pipeline Products & Ongoing Clinical Trials Overview 88

Biomarker Test – Spondyloarthropathy – Product Status 88

Biomarker Test – Spondyloarthropathy – Product Description 88

GoodGut SL Pipeline Products & Ongoing Clinical Trials Overview 89

RAID-Prediction – Product Status 89

RAID-Prediction – Product Description 89

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Accre Diagnostic Assay – Anti-CCP – Product Status 90

Accre Diagnostic Assay – Anti-CCP – Product Description 91

Accre Diagnostic Assay – FR-CRP – Product Status 91

Accre Diagnostic Assay – FR-CRP – Product Description 91

Accre Diagnostic Assay – hs-CRP – Product Status 92

Accre Diagnostic Assay – hs-CRP – Product Description 92

Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

Biomarker Assay – Inflammatory Disease – Product Status 93

Biomarker Assay – Inflammatory Disease – Product Description 94

Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 95

CLIA Waived Diagnostic Test – Rheumatoid Arthritis – Product Status 95

CLIA Waived Diagnostic Test – Rheumatoid Arthritis – Product Description 95

InterVenn BioSciences Pipeline Products & Ongoing Clinical Trials Overview 96

Treatment Monitoring Panel – Inflammation – Product Status 96

Treatment Monitoring Panel – Inflammation – Product Description 96

IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 97

Diagnostic Test – Rheumatoid Arthritis – Product Status 97

Diagnostic Test – Rheumatoid Arthritis – Product Description 97

IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 98

Diagnostic Assay – Inflammatory Diseases – Product Status 98

Diagnostic Assay – Inflammatory Diseases – Product Description 98

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 99

Anti-PAD3 Based Diagnostic Assay – Rheumatoid Arthritis – Product Status 99

Anti-PAD3 Based Diagnostic Assay – Rheumatoid Arthritis – Product Description 99

Biomarker Assay – Rheumatoid Arthritis – Product Status 100

Biomarker Assay – Rheumatoid Arthritis – Product Description 100

KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Diagnostic Assay – Collagen Synthesis – Product Status 101

Diagnostic Assay – Collagen Synthesis – Product Description 101

Korea Basic Science Institute Pipeline Products & Ongoing Clinical Trials Overview 102

Rapid Diagnostic Paper Slip Chip Test – Product Status 102

Rapid Diagnostic Paper Slip Chip Test – Product Description 102

Ladon Therapeutics Kft Pipeline Products & Ongoing Clinical Trials Overview 103

Diagnostic Tool Kit – Inflammatory Bowel Disease – Product Status 103

Diagnostic Tool Kit – Inflammatory Bowel Disease – Product Description 103

Leiden University Pipeline Products & Ongoing Clinical Trials Overview 104

Biomarker Assay – Rheumatoid Arthritis – Product Status 104

Biomarker Assay – Rheumatoid Arthritis – Product Description 104

LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 105

LifeAssays hsCRP – Product Status 105

LifeAssays hsCRP – Product Description 105

LightDeck Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106

LightDeck Inflammation Panel – Product Status 106

LightDeck Inflammation Panel – Product Description 106

Mabdx Inc Pipeline Products & Ongoing Clinical Trials Overview 107

Diagnostic Test – Systemic Inflammatory Response Syndrome – Product Status 107

Diagnostic Test – Systemic Inflammatory Response Syndrome – Product Description 107

Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 108

EasyRA Analyzer – RF Assay – Product Status 108

EasyRA Analyzer – RF Assay – Product Description 108

Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 109

Diagnostic Test – Inflammatory Bowel Disease – Product Status 109

Diagnostic Test – Inflammatory Bowel Disease – Product Description 109

Morehouse School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 110

Diagnostic Assay – Shift Work Exposure – Product Status 110

Diagnostic Assay – Shift Work Exposure – Product Description 110

MyHealthChecked plc Pipeline Products & Ongoing Clinical Trials Overview 111

myLotus Diagnostic Test – Inflammation – Product Status 111

myLotus Diagnostic Test – Inflammation – Product Description 111

MYND Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

Diagnostic Test – Inflammatory Disease – Product Status 112

Diagnostic Test – Inflammatory Disease – Product Description 112

Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 113

myPath Psoriatic Arthritis – Product Status 113

myPath Psoriatic Arthritis – Product Description 113

Nagoya City University Pipeline Products & Ongoing Clinical Trials Overview 114

Diagnostic Biomarker Test – Inflammatory Bowel Disease (IBD) – Product Status 114

Diagnostic Biomarker Test – Inflammatory Bowel Disease (IBD) – Product Description 114

Neoteryx LLC Pipeline Products & Ongoing Clinical Trials Overview 115

VAMS Device – Inflammatory Bowel Disease Assay – Product Status 115

VAMS Device – Inflammatory Bowel Disease Assay – Product Description 115

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 116

Diagnostic Test – Pelvic Pain Syndrome – Product Status 116

Diagnostic Test – Pelvic Pain Syndrome – Product Description 116

Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 117

VITROS 4600 – CRP Ultra (MP) Assay – Product Status 117

VITROS 4600 – CRP Ultra (MP) Assay – Product Description 117

Vitros 4600 – Wide-Range CRP Assay – Product Status 118

Vitros 4600 – Wide-Range CRP Assay – Product Description 118

VITROS 5600 – CRP Ultra (MP) Assay – Product Status 118

VITROS 5600 – CRP Ultra (MP) Assay – Product Description 119

Vitros 5600 – Wide-Range CRP Assay – Product Status 119

Vitros 5600 – Wide-Range CRP Assay – Product Description 119

Vitros XT 7600 – Wide-Range CRP Assay – Product Status 120

Vitros XT 7600 – Wide-Range CRP Assay – Product Description 120

Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 121

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test – Product Status 121

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test – Product Description 121

Paragraf Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

PCT/CRP Test – Product Status 122

PCT/CRP Test – Product Description 122

Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 123

Diagnostic Test – Inflammatory Diseases – Product Status 123

Diagnostic Test – Inflammatory Diseases – Product Description 123

Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 124

Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Status 124

Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Description 124

Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 125

NavigAID – Rheumatoid Arthritis – Product Status 125

NavigAID – Rheumatoid Arthritis – Product Description 125

ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

ImmiPrint Diagnostic Test – Inflammatory Diseases – Product Status 126

ImmiPrint Diagnostic Test – Inflammatory Diseases – Product Description 126

QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

Qscheck – BISCRP Kit – Product Status 127

Qscheck – BISCRP Kit – Product Description 127

Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 128

Biomarker Assay – Rheumatoid Arthritis – Product Status 128

Biomarker Assay – Rheumatoid Arthritis – Product Description 128

Blood-Based Diagnostic Test – Myocarditis – Product Status 129

Blood-Based Diagnostic Test – Myocarditis – Product Description 129

Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 130

TrailblazeDx Test – Rheumatoid Arthritis – Product Status 130

TrailblazeDx Test – Rheumatoid Arthritis – Product Description 130

TrailblazeTx Test – Rheumatoid Arthritis – Product Status 131

TrailblazeTx Test – Rheumatoid Arthritis – Product Description 131

ROMEG Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 132

Companion Diagnostic Test – Rheumatology – Product Status 132

Companion Diagnostic Test – Rheumatology – Product Description 132

Scailyte AG Pipeline Products & Ongoing Clinical Trials Overview 133

Companion Diagnostic Test – Refractory Rheumatoid Arthritis – Product Status 133

Companion Diagnostic Test – Refractory Rheumatoid Arthritis – Product Description 133

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 134

ADVIA Centaur CP Immunoassay System – TNFa Assay – Product Status 135

ADVIA Centaur CP Immunoassay System – TNFa Assay – Product Description 135

ADVIA Centaur XP Immunoassay System – TNFa Assay – Product Status 135

ADVIA Centaur XP Immunoassay System – TNFa Assay – Product Description 136

ADVIA Centaur XPT Immunoassay System – TNFa Assay – Product Status 136

ADVIA Centaur XPT Immunoassay System – TNFa Assay – Product Description 136

Atellica IM Analyzer – IL-6 Assay – Product Status 137

Atellica IM Analyzer – IL-6 Assay – Product Description 137

Atellica IM Analyzer – LBP Assay – Product Status 137

Atellica IM Analyzer – LBP Assay – Product Description 138

Atellica Solution – IL2R Assay – Product Status 138

Atellica Solution – IL2R Assay – Product Description 138

Atellica Solution – TNFa Assay – Product Status 139

Atellica Solution – TNFa Assay – Product Description 139

IMMULITE 2000 Immunoassay System – IL-10 Assay – Product Status 139

IMMULITE 2000 Immunoassay System – IL-10 Assay – Product Description 140

IMMULITE 2000 Immunoassay System – IL-1B Assay – Product Status 140

IMMULITE 2000 Immunoassay System – IL-1B Assay – Product Description 140

IMMULITE 2000 Immunoassay System – IL-8 Assay – Product Status 140

IMMULITE 2000 Immunoassay System – IL-8 Assay – Product Description 141

IMMULITE 2000 Immunoassay System – TNFa Assay – Product Status 141

IMMULITE 2000 Immunoassay System – TNFa Assay – Product Description 141

IMMULITE 2000 XPi Immunoassay System – IL-10 Assay – Product Status 141

IMMULITE 2000 XPi Immunoassay System – IL-10 Assay – Product Description 142

IMMULITE 2000 XPi Immunoassay System – IL-1B Assay – Product Status 142

IMMULITE 2000 XPi Immunoassay System – IL-1B Assay – Product Description 142

IMMULITE 2000 XPi Immunoassay System – IL-8 Assay – Product Status 142

IMMULITE 2000 XPi Immunoassay System – IL-8 Assay – Product Description 143

IMMULITE 2000 XPi Immunoassay System – TNFa Assay – Product Status 143

IMMULITE 2000 XPi Immunoassay System – TNFa Assay – Product Description 143

Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Sgx Clarity System – SIRS Rule-Out / Rule-In Test – Product Status 144

Sgx Clarity System – SIRS Rule-Out / Rule-In Test – Product Description 144

SMC Endothelin Assay – Product Status 145

SMC Endothelin Assay – Product Description 145

SMC IL-17A Assay – Product Status 145

SMC IL-17A Assay – Product Description 146

SMC IL-6 Assay – Product Status 146

SMC IL-6 Assay – Product Description 146

SMC TNF-Alpha Assay – Product Status 147

SMC TNF-Alpha Assay – Product Description 147

SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 148

SomaSignal Test – Rheumatoid Arthritis – Product Status 148

SomaSignal Test – Rheumatoid Arthritis – Product Description 148

SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 149

Spinchip – Interleukin 6 Assay – Product Status 149

Spinchip – Interleukin 6 Assay – Product Description 149

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 150

Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers – Product Status 150

Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers – Product Description 150

StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Status 151

Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Description 151

Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview 152

Diagnostic Test – IBD – Product Status 152

Diagnostic Test – IBD – Product Description 152

Diagnostic Test – Rheumatoid Arthritis – Product Status 153

Diagnostic Test – Rheumatoid Arthritis – Product Description 153

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 154

Molecular Pathology Test – Lupus – Product Status 154

Molecular Pathology Test – Lupus – Product Description 154

Molecular Pathology Test – Psoriasis – Product Status 155

Molecular Pathology Test – Psoriasis – Product Description 155

Molecular Pathology Test – Rheumatoid Arthritis – Product Status 155

Molecular Pathology Test – Rheumatoid Arthritis – Product Description 156

The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 157

Diagnostic Test – Acute Rheumatic Fever – Product Status 157

Diagnostic Test – Acute Rheumatic Fever – Product Description 157

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 158

Phadia 5000 Laboratory System – CCP Test – Product Status 158

Phadia 5000 Laboratory System – CCP Test – Product Description 158

Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 159

Diagnostic Assay – Rheumatoid Arthritis – Product Status 159

Diagnostic Assay – Rheumatoid Arthritis – Product Description 159

University Health Network Pipeline Products & Ongoing Clinical Trials Overview 160

Biomarker Test – Rheumatoid Arthritis – Product Status 160

Biomarker Test – Rheumatoid Arthritis – Product Description 160

University Hospital Hradec Kralove Pipeline Products & Ongoing Clinical Trials Overview 161

Point-Of-Care Test – Intra-Amniotic Inflammation – Product Status 161

Point-Of-Care Test – Intra-Amniotic Inflammation – Product Description 161

University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 162

Diagnostic Assay – Rheumatoid Arthritis – Product Status 162

Diagnostic Assay – Rheumatoid Arthritis – Product Description 162

University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 163

Diagnostic Test – Rheumatic Fever – Product Status 163

Diagnostic Test – Rheumatic Fever – Product Description 163

University of California Pipeline Products & Ongoing Clinical Trials Overview 164

Biomarker Test – Inflammatory Bowel Disease – Product Status 164

Biomarker Test – Inflammatory Bowel Disease – Product Description 164

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 165

Diagnostic Biomarker Test – Inflammatory Bowel Disease – Product Status 165

Diagnostic Biomarker Test – Inflammatory Bowel Disease – Product Description 165

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 166

Diagnostic Test – Endometriosis And Inflammatory Disease – Product Status 166

Diagnostic Test – Endometriosis And Inflammatory Disease – Product Description 166

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 167

Prognostic Tool – Inflammation – Product Status 167

Prognostic Tool – Inflammation – Product Description 167

University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 168

C3aR-Based Diagnostic Assay – Product Status 168

C3aR-Based Diagnostic Assay – Product Description 168

University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 169

Blood-Based Diagnostic Test – Endometriosis – Product Status 169

Blood-Based Diagnostic Test – Endometriosis – Product Description 169

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 170

Biomarker Based Assay – Rheumatoid Arthritis – Product Status 170

Biomarker Based Assay – Rheumatoid Arthritis – Product Description 170

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 171

PBMC-Based Companion Diagnostic Test – Product Status 171

PBMC-Based Companion Diagnostic Test – Product Description 171

University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 172

Diagnostic Test – Arthritis – Product Status 172

Diagnostic Test – Arthritis – Product Description 172

University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 173

CD-Medics Test – RA – Product Status 173

CD-Medics Test – RA – Product Description 173

Glossary 188

Figures

Inflammatory Disease Markers – Pipeline Products by Stage of Development 18

Inflammatory Disease Markers – Pipeline Products by Segment 19

Inflammatory Disease Markers – Pipeline Products by Territory 20

Inflammatory Disease Markers – Pipeline Products by Regulatory Path 21

Inflammatory Disease Markers – Pipeline Products by Estimated Approval Date 22

Inflammatory Disease Markers – Ongoing Clinical Trials 23

Frequently asked questions

Inflammatory Disease Markers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Inflammatory Disease Markers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Inflammatory Disease Markers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Inflammatory Disease Markers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.